In this study the investigators observe the investigation, whether the new method for Boost-Irradiation with the Intrabeam Device of Zeiss Germany influences local recurrence, acute and late effects of Radiotherapy, overall survival, quality of life and cosmesis.
Study Type
OBSERVATIONAL
Enrollment
163
KMünsterlingen
Münsterlingen, Thurgau, Switzerland
number of Participants with local recurrence histologically proven
Recurrence of breast cancer proven by histology
Time frame: up to 10 years
observation of acute and late effects of Radiotherapy
acute effects of Radiotherapy are assessed by Common Toxicity Criteria for Adverse Effects (CTCAE Version 4.0) and late effects of Radiotherapy are assessed by Late Effects Normal Tissue Subjective Objective Management Analysis (LENT-SOMA)
Time frame: up to 10 years
Overall survival
The number of Patients who died is assessed.
Time frame: up to 10 years
Quality of life
Quality of life is assessed by European Organization for Research and Treatment of Cancer (EORTC) quality of life questionnaires (QLQ) cancer modul (C30) EORTC-QLQ-C30 version 3.0 and breast cancer modul (BR23) EORTC-QLQ-BR23
Time frame: up to 10 years
Cosmesis
Cosmesis is assessed by Photographs and evaluated automatically.
Time frame: up to 10 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.